Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later
NCT ID: NCT06644976
Last Updated: 2024-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2024-08-20
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Loss and Complications of Internal Fixation of Femoral Neck Fractures in Patients Treated With Clopidogrel
NCT00749710
Assessment of a Procedure for Managing Oral Anticoagulants (NACO) in the Management of Fractures
NCT06220422
Evaluation of Perioperative Management of Curative Anticoagulants in the Geriatric Perioperative Unit in Patient Hospitalized for Femoral Neck Fracture.
NCT05286671
A New Clinical Pathway for Patients With Fractured Neck of Femur
NCT00667914
Anterolateral Versus Posterior Approach for Total Hip Arthroplasty After Displaced Femoral Neck Fracture
NCT01484405
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
early surgery
femoral neck CRIF
femoral neck fracture CRiF while under noac. no special intervention beside taking blood test for drug levels
late surgery
femoral neck CRIF
femoral neck fracture CRiF while under noac. no special intervention beside taking blood test for drug levels
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
femoral neck CRIF
femoral neck fracture CRiF while under noac. no special intervention beside taking blood test for drug levels
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
* anti platelet therapy (aspirin is not included)
* creatinine clearance under 50
* active anti cancer therapy
* ITP patients
* non capable of making inform consent
* patients which decide not to proceed with the expeirment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meir Hospital, Kfar Saba, Israel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maron Talmore
Dr. meron pinchas talmor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meir Hospital
Kfar Saba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
mmc000723
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.